Overview
Mark Cragg practices practicing medicine in Southampton, United Kingdom.
Mr. Cragg is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), and Leukemia.
He is actively involved in clinical research, co-authoring 168 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mark S. Cragg
Is Mark S. Cragg a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?
MediFind is an objective health platform that identifies experts based on real-world data. Mark S. Cragg is classified as an Distinguished expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mark S. Cragg participate in research or clinical trials?
Yes. Mark S. Cragg has published 168 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Mark S. Cragg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Mr. Cragg isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Cragg isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Advanced
- B-Cell LymphomaMr. Cragg isAdvanced. Learn about B-Cell Lymphoma.
- LeukemiaMr. Cragg isAdvanced. Learn about Leukemia.
- Non-Hodgkin LymphomaMr. Cragg isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Small Lymphocytic Lymphoma (SLL)
- Systemic Lupus Erythematosus (SLE)
- Experienced
- ArthritisMr. Cragg isExperienced. Learn about Arthritis.
- Burkitt LymphomaMr. Cragg isExperienced. Learn about Burkitt Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Cragg isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Embryonal Tumor with Multilayered Rosettes
- Follicular LymphomaMr. Cragg isExperienced. Learn about Follicular Lymphoma.
- NecrosisMr. Cragg isExperienced. Learn about Necrosis.
- NeuroblastomaMr. Cragg isExperienced. Learn about Neuroblastoma.
- Prolymphocytic LeukemiaMr. Cragg isExperienced. Learn about Prolymphocytic Leukemia.
- Rheumatoid Arthritis (RA)Mr. Cragg isExperienced. Learn about Rheumatoid Arthritis (RA).
- Thymic Epithelial TumorMr. Cragg isExperienced. Learn about Thymic Epithelial Tumor.
- TriploidyMr. Cragg isExperienced. Learn about Triploidy.
- Trophoblastic Tumor Placental SiteMr. Cragg isExperienced. Learn about Trophoblastic Tumor Placental Site.